A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Getting a cold once or twice a few months is normal, but what about a persistently blocked nose that lingers for weeks and ...

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

A nasal COVID-19 vaccine developed by US biotech CyanVac has produced encouraging results in an early trial, showing potential to offer broader immunity and easier delivery than current injections.

"We are thrilled to bring the SONU Band to Android users now," said Dr. Paramesh Gopi, founder and CEO of SoundHealth. "Our ...

The FTC sued Xlear after it marketed its spray as a covid preventative. The Trump administration dropped the suit, but the ...

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable ...

A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator ...

"Imagine like a speck of baby powder; that's how much could be a lethal dosage of carfentanil," said Brian McNeal, public ...